1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with carbamates in 13 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (carbamates) | Trials (carbamates) | Recent Studies (post-2010) (carbamates) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 13,717 | 985 | 4,744 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kertscher, HP; Ostermann, G; Schmidt, B | 1 |
| Castro-Faria-Neto, HC; Cordeiro, RS; Henriques, MG; Martins, MA; Silva, PM; Silva, PS; Vargaftig, BB | 1 |
| Castanheira, JR; Cordeiro, RS; Faria Neto, HC; Martins, MA; Silva, PM; Vargaftig, BB | 1 |
| Broquet, C; Godfroid, JJ; Heymans, F | 1 |
| Carroll, ML; Kerwar, SS; Kohler, CA; Pickett, WC; Schaub, RE; Torley, LW; Trova, MP; Wissner, A | 1 |
| Bellahsene, T; Blavet, N; Dive, G; Favre, E; Godfroid, JJ; Le Texier, L; Pirotzky, E; Redeuilh, C | 1 |
| Isono, K; Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J; Yamawaki, I | 1 |
| Durán, WN; Kim, DD; Ramírez, MM | 1 |
| Bensaid, O; Cisternino, S; Clayette, P; Dereuddre-Bosquet, N; Dong, CZ; Dormont, D; Heymans, F; Huet, J; Lamouri, A; Martin, M; Redeuilh, C; Rousselle, C; Scherrmann, JM; Serradji, N | 1 |
| Chiang, KP; Cravatt, BF; Niessen, S; Saghatelian, A | 1 |
| Gelb, MH; Giannattasio, G; Granata, F; Lai, Y; Lambeau, G; Leslie, CC; Marone, G; Mounier, CM; Nallan, L; Oslund, R; Triggiani, M | 1 |
| Chen, Y; Dong, C; Jiang, P; Serradji, N; Wang, Q; Xu, X; Yang, J; Zhang, W | 1 |
| Bessi, VL; Bitencourt, CS; Borgeat, P; Faccioli, LH; Hamdan, L; Huynh, DN; Lefebvre, JS; Lévesque, T; Marleau, S; Ménard, L; Sohouhenou, F | 1 |
13 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and carbamates
| Article | Year |
|---|---|
[PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship].
Topics: Blood Platelets; Carbamates; Humans; In Vitro Techniques; Molecular Conformation; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 1992 |
Pharmacological modulation of 2-methyl-carbamate-PAF induced rat paw oedema.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbamates; Diterpenes; Edema; Female; Ginkgolides; Lactones; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections.
Topics: Animals; Carbamates; Carrageenan; Drug Tolerance; Edema; Inflammation; Injections; Injections, Intravenous; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serotonin | 1986 |
Synthesis of ether phospholipids.
Topics: Carbamates; Chemical Phenomena; Chemistry; Lysophospholipids; Phospholipids; Plasmalogens; Platelet Activating Factor | 1986 |
Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
Topics: Amides; Animals; Carbamates; Imides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Aggregation; Pyridinium Compounds; Rabbits; Structure-Activity Relationship | 1993 |
Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity.
Topics: Carbamates; Cholinesterase Inhibitors; Esters; Furans; Isomerism; Platelet Activating Factor; Structure-Activity Relationship | 1996 |
A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels.
Topics: Arginine Vasopressin; Bradykinin; Bronchi; Carbamates; Cell Line; Epithelial Cells; Humans; Large-Conductance Calcium-Activated Potassium Channels; Peptides; Phenylcarbamates; Platelet Activating Factor; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Type C Phospholipases | 1998 |
Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch.
Topics: Administration, Topical; Animals; Arterioles; Biological Transport; Carbamates; Cheek; Cricetinae; Dose-Response Relationship, Drug; Enzyme Activation; Estrenes; Male; Mesocricetus; Microcirculation; Permeability; Phenylcarbamates; Phospholipases; Platelet Activating Factor; Pyrrolidinones; Type C Phospholipases; Vasoconstriction | 2000 |
Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity.
Topics: Animals; Anti-HIV Agents; Biological Availability; Blood-Brain Barrier; Carbamates; Cells, Cultured; HIV-1; Humans; In Vitro Techniques; Macrophages; Male; Mice; Permeability; Piperazines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Virus Replication | 2004 |
An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling.
Topics: Carbamates; Carboxylic Ester Hydrolases; Cell Line, Tumor; Chromatography, High Pressure Liquid; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Ketones; Lysophospholipids; Ovarian Neoplasms; Phospholipid Ethers; Platelet Activating Factor; RNA Interference; Sensitivity and Specificity; Signal Transduction; Sterol Esterase | 2006 |
Expression of phospholipases A2 in primary human lung macrophages: role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesis.
Topics: Arachidonic Acid; Carbamates; Cells, Cultured; Enzyme Inhibitors; Exocytosis; Fluoroimmunoassay; Glucuronidase; Group IV Phospholipases A2; Humans; Immunoblotting; Indolizines; Ionophores; Lipopolysaccharides; Macrophages, Alveolar; Platelet Activating Factor; Polymerase Chain Reaction | 2009 |
PMS-1077, a PAF antagonist, induced differentiation of HL-60 cells with its novel activity.
Topics: Antineoplastic Agents; Carbamates; Cell Cycle; Cell Differentiation; Cell Proliferation; Drug Evaluation, Preclinical; HL-60 Cells; Humans; Lymphocytes; Phagocytosis; Piperazines; Platelet Activating Factor; Platelet Aggregation Inhibitors; Up-Regulation | 2010 |
Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.
Topics: Amidines; Animals; Azepines; Biological Assay; Carbamates; Dermis; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Extremities; Inflammation; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Neutrophil Infiltration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propionates; Quinolines; Rabbits; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Reperfusion Injury; Triazoles | 2013 |